BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 16849770)

  • 1. Tamoxifen-related vasculitis.
    Baptista MZ; Prieto VG; Chon S; Hortobagyi GN; Esteva FJ
    J Clin Oncol; 2006 Jul; 24(21):3504-5. PubMed ID: 16849770
    [No Abstract]   [Full Text] [Related]  

  • 2. Tamoxifen and the factor V Leiden mutation.
    Cuzick J
    J Natl Cancer Inst; 2010 Jul; 102(13):918-9. PubMed ID: 20554943
    [No Abstract]   [Full Text] [Related]  

  • 3. Caring for the breast cancer survivor.
    Abdel-Razeq H
    Am J Med; 2011 Feb; 124(2):e11; author reply e13. PubMed ID: 21295181
    [No Abstract]   [Full Text] [Related]  

  • 4. Tamoxifen and purpuric vasculitis: a case report.
    Betto P; Gennari E; Germi L; Bonoldi E; Scalco G; Tosti A
    J Eur Acad Dermatol Venereol; 2008 Jun; 22(6):762-3. PubMed ID: 18031499
    [No Abstract]   [Full Text] [Related]  

  • 5. Tamoxifen-associated vasculitis in a breast cancer patient.
    Candelaria M; Hurtado-Monroy R; Vargas-Viveros P; Carrillo-Muñnoz S; Duenas-Gonzalez A
    World J Surg Oncol; 2007 Jan; 5():9. PubMed ID: 17244373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of hormone replacement therapy on tamoxifen-induced vasomotor symptoms.
    Sestak I; Kealy R; Edwards R; Forbes J; Cuzick J
    J Clin Oncol; 2006 Aug; 24(24):3991-6. PubMed ID: 16921052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tamoxifen side effects may be attributable to other causes.
    Jones J
    J Natl Cancer Inst; 2001 Jan; 93(1):11-2. PubMed ID: 11136833
    [No Abstract]   [Full Text] [Related]  

  • 8. Tamoxifen: an enduring star.
    Veronesi U; Maisonneuve P; Decensi A
    J Natl Cancer Inst; 2007 Feb; 99(4):258-60. PubMed ID: 17312297
    [No Abstract]   [Full Text] [Related]  

  • 9. Sowing the soil for cure? Results of the ABCSG-12 trial open a new chapter in the evolving adjuvant bisphosphonate story in early breast cancer.
    Bedard PL; Body JJ; Piccart-Gebhart MJ
    J Clin Oncol; 2009 Sep; 27(25):4043-6. PubMed ID: 19652062
    [No Abstract]   [Full Text] [Related]  

  • 10. Tumor 'flare' hypercalcemia--an additional indication for bisphosphonates?
    Nikolic-Tomasević Z; Jelic S; Popov I; Radosavljević D; Mitrović L
    Oncology; 2001; 60(2):123-6. PubMed ID: 11244326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New Insights Into Nonadherence With Adjuvant Endocrine Therapy Among Young Women With Breast Cancer.
    Rosenberg SM; Partridge AH
    J Natl Cancer Inst; 2015 Oct; 107(10):. PubMed ID: 26307642
    [No Abstract]   [Full Text] [Related]  

  • 12. Antiestrogens: the past and the future.
    Bentrem DJ; Jordan VC
    Zentralbl Gynakol; 2002 Dec; 124(12):551-8. PubMed ID: 12822068
    [No Abstract]   [Full Text] [Related]  

  • 13. Death due to liver failure during endocrine therapy for premenopausal breast cancer.
    Rabaglio M; Ruepp B;
    Acta Oncol; 2010 Aug; 49(6):874-6. PubMed ID: 20482225
    [No Abstract]   [Full Text] [Related]  

  • 14. [Tamoxifen; wider indications, more frequent controls?].
    Rutgers EJ; Nortier JW; Beex I;
    Ned Tijdschr Geneeskd; 2001 Sep; 145(36):1766-7. PubMed ID: 11589197
    [No Abstract]   [Full Text] [Related]  

  • 15. Tamoxifen-induced hypercalcemia in metastatic breast cancer.
    Nemoto T; Rosner DH; Patel DJ; Wettingfeld RF; Bambrah SS; Dao TL
    N Y State J Med; 1980 Dec; 80(13):1980-2. PubMed ID: 6937756
    [No Abstract]   [Full Text] [Related]  

  • 16. Should urogenital atrophy in breast cancer survivors be treated with topical estrogens?
    Trinkaus M; Chin S; Wolfman W; Simmons C; Clemons M
    Oncologist; 2008 Mar; 13(3):222-31. PubMed ID: 18378532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose tamoxifen in breast cancer bone metastasis.
    Stathopoulos GP; Trafalis D
    J BUON; 2013; 18(2):532-4. PubMed ID: 23818373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fatal hypercalcemia in tamoxifen. Chief symptom: increasing somnolence in a 68-year-old patient].
    Mayer O; Hricko P; Bernhard P; Leibundgut U
    Praxis (Bern 1994); 1999 Nov; 88(46):1923-4. PubMed ID: 10593148
    [No Abstract]   [Full Text] [Related]  

  • 19. Life-threatening tamoxifen-induced hypercalcaemia.
    Mulvenna PM; Wright AJ; Podd TJ
    Clin Oncol (R Coll Radiol); 1999; 11(3):193-5. PubMed ID: 10465476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tamoxifen-induced vasculitis.
    Kulkarni U; Nayak V; Prabhu MM; Rao R
    J Oncol Pharm Pract; 2020 Apr; 26(3):735-737. PubMed ID: 31359833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.